This page is about peppermint oil for IBS or the Irritable Bowel Syndrome. It is also known by the trade names Mintec, Apercap or Colpermin.
It is a natural treatment and can provide excellent symptom relief, particularly with the cramps that are common to the condition.
On this page you can learn more about the indications, dosage and potential side effects.
Select A Topic:
It is used in the treatment of Irritable Bowel Syndrome and abdominal colic.
If you are sensitive to Menthol you should avoid this treatment. You should also discuss with a health care professional if you are;
Side effects are uncommon, but can include heartburn, perianal irritation (itchy bottom), rarely allergic reactions (including rash, headache, slow heart rate, muscle tremor and ataxia - stumbling and falls)
It comes as capsules and should be taken at a dose of 1 or 2, swallowed whole not broken so as to prevent mouth irritation, with water three times a day up to two to three months usually.
This dose can be adjusted after discussion with your doctor.
These capsules are an excellent way of helping improve the symptoms of colic.
They are generally non-toxic, readily available and a natural way of helping to improve symptoms.
They can be taken three times a day so this provides regular relief and they are relatively cheap to buy and available off prescription.
Most patients report some relief with them.
If you look at the evidence base for peppermint for IBS, studies have generally been quite small, but have shown overall benefit.
1) Mintoil in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L.Dig Liver Dis. 2007 Jun;39(6):530-6. Epub 2007 Apr 8.
2) Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. Kline RM, Kline JJ, Di Palma J, Barbero GJ.J Pediatr. 2001 Jan;138(1):125-8.
3) Liu JH, Chen GH, Yeh HZ, et al. Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial. J Gastroenterol 1997;32:765-8
PLEASE NOTE: Whilst this website has taken every care to make sure the information is correct, we cannot accept any liability for any of the above information.
Like The Page?